【结 构 式】 |
【药物名称】LY-382924 【化学名称】2,6-Di-tert-butyl-4-[4-[4-[2-(N-ethyl-N-methylamino)ethyl]phenoxymethyl]oxazol-2-yl]phenol hydrochloride 【CA登记号】206122-67-0, 206122-66-9 (mono HCl salt) 【 分 子 式 】C29H41ClN2O3 【 分 子 量 】501.11472 |
【开发单位】Lilly (Originator) 【药理作用】Cerebrovascular Diseases, Treatment of, Ischemic Stroke, Treatment of, NEUROLOGIC DRUGS, Stroke, Treatment of, Antioxidants |
合成路线1
1) The N-acylation of DL-serine (I) with 3,5-di-tert-butyl-4-hydroxybenzoic acid by means of carbonyldiimidazole (CDI) in THF gives the acylated serine (III), which is cyclized by means of CBr4/triphenylphosphine/imidazole in acetonitrile to yields the oxazoline (IV). The dehydrogenation of (IV) with activated MnO2 in acetone affords 2-(3,5-di-tert-butyl-4-hydroxyphenyl)oxazole-4-carboxylic acid methyl ester (V), which is reduced with LiBH4 in THF/methanol giving the oxazolylmethnaol (VI). The reaction of (VI) with Br2/triphenylphosphine in acetonitrile yields the bromomethyl derivtive (VII), which is condensed with N-ethyl-N-[2-(4-hydroxyphenyl)ethyl]formamide (VIII) by means of NaH in THF to afford the formylated precursor (IX). Finally, this compound is converted into LY-382924 by reduction of the formyl group with AlH3 (LiAlH4/H2SO4) in THF and treatmnt with HCl gas in CHCl3. 2) The intermediate N-ethyl-N-[2-(4-hydroxyphenyl)ethyl]formamide (VIII) has been obtained as follows: The acylation of 2-(4-hydroxyphenyl)ethylamine (X) with acetic anhydride gives the acetamide (XI), which is reduced with LiAlH4 to the secondary amine (XII). Finally, this amine is formylated with formic acid and carbonyldiimidazole (CDI) in THF.
【1】 Heinz, L.J.; et al.; Synthesis and biological evaluation of a novel series of antioxidants for the treatment of global cerebral ischemia. 217th ACS Natl Meet (March 21 1999, Anaheim) 1998, Abst MEDI 130. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14224 | Serine, methyl ester; methyl 2-amino-3-hydroxypropanoate | 2104-89-4 | C4H9NO3 | 详情 | 详情 |
(II) | 19980 | 3,5-di(tert-butyl)-4-hydroxybenzoic acid | 1421-49-4 | C15H22O3 | 详情 | 详情 |
(III) | 19981 | methyl 2-[[3,5-di(tert-butyl)-4-hydroxybenzoyl]amino]-3-hydroxypropanoate | C19H29NO5 | 详情 | 详情 | |
(IV) | 19982 | methyl 2-[3,5-di(tert-butyl)-4-hydroxyphenyl]-4,5-dihydro-1,3-oxazole-4-carboxylate | C19H27NO4 | 详情 | 详情 | |
(V) | 19983 | methyl 2-[3,5-di(tert-butyl)-4-hydroxyphenyl]-1,3-oxazole-4-carboxylate | C19H25NO4 | 详情 | 详情 | |
(VI) | 19984 | 2,6-di(tert-butyl)-4-[4-(hydroxymethyl)-1,3-oxazol-2-yl]phenol | C18H25NO3 | 详情 | 详情 | |
(VII) | 19985 | 4-[4-(bromomethyl)-1,3-oxazol-2-yl]-2,6-di(tert-butyl)phenol | C18H24BrNO2 | 详情 | 详情 | |
(VIII) | 19986 | ethyl(4-hydroxyphenethyl)formamide | C11H15NO2 | 详情 | 详情 | |
(IX) | 19987 | 4-([2-[3,5-di(tert-butyl)-4-hydroxyphenyl]-1,3-oxazol-4-yl]methoxy)phenethyl(ethyl)formamide | C29H38N2O4 | 详情 | 详情 | |
(X) | 19988 | 4-(2-Aminoethyl)phenol; Tyramine | 51-67-2 | C8H11NO | 详情 | 详情 |
(XI) | 19989 | N-(4-hydroxyphenethyl)acetamide | C10H13NO2 | 详情 | 详情 | |
(XII) | 19990 | 4-[2-(ethylamino)ethyl]phenol | C10H15NO | 详情 | 详情 |